Cantel Medical Reports Results For Quarter Ended April 30, 2006

CANTEL MEDICAL CORP. (NYSE:CMN - News) reported a 20% increase in net income to $4,583,000, or $0.28 per diluted share, on a 29% increase in sales to $65,358,000 for its third quarter ended April 30, 2006. This compares with net income of $3,809,000, or $0.23 per diluted share, on sales of $50,534,000 for the quarter ended April 30, 2005. For the nine months ended April 30, 2006, the Company reported a 14% increase in net income to $12,258,000, or $0.75 per diluted share, on a 29% increase in sales to $187,215,000. This compares with net income of $10,791,000, or $0.67 per diluted share, on sales of $145,412,000 for the nine months ended April 30, 2005. The increases in net sales were principally due to Crosstex, which was acquired on August 1, 2005.

Back to news